Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Sevara Khudayarova

9 та иш

Tashkent Medical Academy, Neurology, Tashkent, Uzbekistan

  1. Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease

    Sevara Khudayarova, G. Rakhmatullaeva, K. Khalimova

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20200 иқтибос
    ABI

  2. Sleep disorders in patients with chronic kidney disease

    Sevara Khudayarova, Gulnara Rakhatullaeva

    МақолаHealth and Lifestyle StudiesJournal of the Neurological Sciences20210 иқтибос
    ABI

  3. FEATURES OF COGNITIVE DISORDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND THE EFFECT OF CYSTATIN C ON IT DEPENDING ON THE STAGE OF THE DISEASE

    Sevara Khudayarova

    МақолаNeurological Disorders and TreatmentsFrontline Medical Sciences and Pharmaceutical Journal20220 иқтибос
    ABI

  4. Cognitive disorders in patients with chronic kidney disease(CKD) and its relationship with the concentration in the blood of the biomarker of kidney damage cystatin C

    Sevara Khudayarova, Gulnara Rakhmatullaevna

    МақолаNeurological Disorders and TreatmentsJournal of the Neurological Sciences20230 иқтибос
    ABI

  5. The role of brain-derived neurotrophic factor during Parkinson's disease

    Bahtigul Holmuratova, Nilufar Rashidova, K. Khalimova +1

    МақолаAutism Spectrum Disorder ResearchParkinsonism & Related Disorders20240 иқтибос
    ABI

  6. Examination of cognitive function in Parkinson's disease patients with chronic kidney disease

    Sevara Khudayarova, G.K. Rakhmatullayeva, Bahtigul Holmuratova

    МақолаDementia and Cognitive Impairment ResearchParkinsonism & Related Disorders20240 иқтибос
    ABI

  7. Vascular remodeling in patients with CKD as a risk factor for the development of vascular Parkinsonism

    Sevara Khudayarova, G. Rakhmatullayeva, Bahtigul Holmuratova

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20240 иқтибос
    ABI

  8. Cystatin C as a Biomarker for the Development of Parkinson disease in Patients with Chronic Kidney Disease

    Sevara Khudayarova, G.K. Rakhmatullayeva

    МақолаDialysis and Renal Disease ManagementParkinsonism & Related Disorders20250 иқтибос
    ABI

  9. Efficacy of ocrelizumab in primary progressive multiple sclerosis

    Sevara Khudayarova, Gulnara Rakhmatullayeva

    МақолаMultiple Sclerosis Research StudiesJournal of the Neurological Sciences20250 иқтибос
    ABI